Jun Liu

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, United States

Disclosure information not submitted.

Presentation(s):

• Comparative safety of biologic and targeted-synthetic DMARDs in patients with rheumatoid arthritis: a multi-database real-world cohort study

  Monday, August 26, 2024
  5:20 PM - 5:25 PM CEST

• Establishing a validation framework of claims-based treatment discontinuation definitions using natural language processing and electronic health records

  Tuesday, August 27, 2024
  1:30 PM - 1:45 PM CEST